The expanding incretin universe: from basic biology to clinical translation
Diabetologia · 2023-10 · 66 (10) · 1765-1779
DOI: 10.1007/s00125-023-05906-7 ↗At a glance
Übersichtsarbeit in Diabetologia, published online on 2023-03-28. Written by Daniel J Drucker and 1 co-authors. Institution: Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. drucker@lunenfeld.c…. Major MEDLINE topics: Incretins, Diabetes Mellitus, Type 2. Cited 245 times so far (Crossref); 174 references. Funded by: CIHR.
Abstract (original language)
Incretin hormones, principally glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1(GLP-1), potentiate meal-stimulated insulin secretion through direct (GIP + GLP-1) and indirect (GLP-1) actions on islet β-cells. GIP and GLP-1 also regulate glucagon secretion, through direct and indirect pathways. The incretin hormone receptors (GIPR and GLP-1R) are widely distributed beyond the pancreas, principally in the brain, cardiovascular and immune systems, gut and kidney, consistent with a broad array of extrapancreatic incretin actions. Notably, the glucoregulatory and anorectic activities of GIP and GLP-1 have supported development of incretin-based therapies for the treatment of type 2 diabetes and obesity. Here we review evolving concepts of incretin action, focusing predominantly on GLP-1, from discovery, to clinical proof of concept, to therapeutic outcomes. We identify established vs uncertain mechanisms of action, highlighting biology conserved across species, while illuminating areas of active investigation and uncertainty that require additional clarification.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. drucker@lunenfeld.ca.
- The Novo Nordisk Foundation Center for Basic Metabolic Research, Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID profiles: Daniel J Drucker, Jens J Holst
Funding
- CIHR
Cite
APA
Drucker, D. J., & Holst, J. J. (2023). The expanding incretin universe: from basic biology to clinical translation. Diabetologia, 66(10), 1765-1779. https://doi.org/10.1007/s00125-023-05906-7
Vancouver
Drucker DJ, Holst JJ. The expanding incretin universe: from basic biology to clinical translation. Diabetologia. 2023;66(10):1765-1779. doi:10.1007/s00125-023-05906-7
BibTeX
@article{Drucker2023,
author = {Drucker, Daniel J and Holst, Jens J},
title = {The expanding incretin universe: from basic biology to clinical translation},
journal = {Diabetologia},
year = {2023},
volume = {66},
number = {10},
pages = {1765--1779},
doi = {10.1007/s00125-023-05906-7}
}
EUVIMED